Expanding Phase III Study of Tyroserleutide for Injection

NCT03516448 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

352

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatocellular Carcinoma

Interventions

DRUG: Gan Fu Le Tablets
DRUG: Tyroserleutide for injection
DRUG: Placebo

Sponsor

Shenzhen Kangzhe Pharmaceutical Co., Ltd.